Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning

Diabetologia

Volumn 41, Issue 9, 1998, Pages 1064-1072

  Nielsen, M F ^a   Dinneen, S ^a   Basu, A ^a   Basu, R ^a   Alzaid, A ^a   Rizza, R R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Gluconeogenesis; Glucose disappearance; Glucose production; Splanchnic glucose uptake

Indexed keywords

C PEPTIDE; CARBOHYDRATE; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; OCTREOTIDE;

ADULT; ARTICLE; CARBOHYDRATE TOLERANCE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GROWTH HORMONE RELEASE; HUMAN; MALE; NIGHT SLEEP; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CIRCADIAN RHYTHM; DIETARY CARBOHYDRATES; FATTY ACIDS, NONESTERIFIED; FEMALE; GASTROINTESTINAL AGENTS; GLUCAGON; GLUCONEOGENESIS; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; LACTIC ACID; MALE; OCTREOTIDE; OXIDATION-REDUCTION; POSTPRANDIAL PERIOD; REFERENCE VALUES; SLEEP; XYLOSE;

EID: 0031872937     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051031     Document Type: Article

References (49)

1. Dinneen S, Gerich J, Rizza R (1992) Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327: 707-713
2. Radziuk J, McDonald TJ, Rubenstein D, Dupre J (1978) Initial splanchnic extraction of ingested glucose in normal man. Metabolism 27: 657-669
3. Ferrannini E, Bjorkman O, Reichard GA Jr et al. (1985) The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes 34: 580-588
4. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA (1986) Postprandial hyperglycaemia in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 77: 1525-1532
5. Rabinowitz D, Klassen GA, Zierler KL (1965) Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J Clin Invest 44: 51-61
6. Rizza RA, Mandarino LJ, Gerich JE (1982) Effect of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663-669
7. Bratusch-Marrain PR, Smith D, DeFronzo RA (1982) The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55: 973-982
8. Moller N, Butler PC, Antsiferov MA, Alberti KGMM (1989) Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32: 105-110
9. Moller N, Jorgensen JOL, Alberti KGMM, Flyvbjerg A, Schmitz O (1990) Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 70: 1179-1186
10. Bak JF, Moller N, Schmitz O (1991) Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol 260:E736-E742
11. Jorgensen JOL, Flyvbjerg A, Lauritzen T, Alberti KGMM, Orskov H, Christiansen JS (1988) Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients. J Clin Endocrinol Metab 67: 36-40
12. Butler P, Kryshak E, Rizza R (1991) Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans. Am J Physiol 260:E513-E520
13. Bratusch-Marrain PR, Gasic S, Waldhausl WK, Nowotny P (1984) The effect of growth hormone on splanchnic glucose and substrate metabolism following oral glucose loading in healthy man. Diabetes 33: 19-25
14. Yalow RS, Goldsmith SJ, Berson SA (1969) Influence of physiologic fluctuations in plasma growth hormone on glucose tolerance. Diabetes 18: 402-408
15. Hartman ML, Faria ACS, Vance ML, Johnson ML, Thorner MO, Veldhuis JD (1991) Temporal structure of in vivo growth hormone secretory events in humans. Am J Physiol 260:E101-E110
16. Jaffe CA, Friberg RD, Barkan AL (1993) Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. J Clin Invest 92: 695-701
17. Levy I, Recasens A, Casamitjana R, Figuerola D (1987) Nocturnal insulin and C-peptide rhythms in normal subjects. Diabetes Care 10: 148-151
18. Shapiro ET, Polonsky KS. Copinschi G et al. (1991) Nocturnal elevation of glucose levels during fasting in non-insulin-dependent diabetes. J Clin Endocrinol Metab 72: 444-454
19. Bolli GB, De Feo P, De Cosmo S et al. (1984) Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 33: 1150-1153
20. Meneilly GS, Elahi D, Minaker KL, Rowe JW (1986) The dawn phenomenon does not occur in normal elderly subjects. J Clin Endocrinol Metab 63: 292-296
21. Marshall L, Molle M, Boschen G, Steiger A, Fehm HL, Born J. (1996) Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration in promoting slow-wave sleep (SWS). J Clin Endocrinol Metab 81: 1009-1013
22. Cappon JP, Ipp E, Brasel JA, Cooper DM (1993) Acute effects of high fat and high glucose meals on the growth hormone response to exercise. J Clin Endocrinol Metab 76: 1418-1422
23. Moberg E, Kollind M, Lins P-E, Adamson U (1994) Acute mental stress impairs insulin sensitivity in IDDM patients. Diabetologia 37: 247-251
24. Karashima T, Cai R, Schally AV (1987) Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release. Life Sci 41: 1011-1019
25. Dinneen S, Alzaid A, Miles J, Rizza R (1993) Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest 92: 2283-2290
26. Karhapää P, Malkki M, Laakso M (1994) Isolated low HDL cholesterol. An insulin-resistant state. Diabetes 43: 411-417
27. Butler PC, Kryshak EJ, Marsh M, Rizza RA (1990) Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Diabetes 39: 1373-1380
28. 3H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used. J Clin Invest 78: 1479-1486
29. Steele R, Wall JS, De Bodo RC, Altszuler N, Kiang SP, Bjerknes C (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24
30. Ciaraldi TP, Molina JM, Olefsky JM. (1991) Insulin action kinetics in adipocytes from obese and non-insulin-dependent diabetes mellitus subjects: Identification of multiple cellular defects in glucose transport. J Clin Endocrinol Metab 72: 876-882
31. Brosnan JT (1982) Pathways of carbon flux in gluconeogeneis. Fed Proc 41: 91-94
32. 14C labeled substrates. Am J Physiol 17: 391-399
33. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634
34. Lecoco FR, Mebane D, Madison LL (1964) The acute effect of hydrocortisone on hepatic glucose output and peripheral glucose utilization. J Clin Invest 43: 237-246
35. Rizza R, Mandarino L, Gerich J (1982) Cortisol induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. J Clin Endocrinol Metah 54: 131-138
36. 2+ dependent mechanism. Diabetes 44: 1345-1348
37. Plat L, Byrne MM, Sturis J et al. (1996) Effects of morning cortisol evaluation on insulin secretion and glucose regulation in humans. Am J Physiol 270:E36-E42
38. MacGorman LR, Rizza RA, Gerich JE (1981) Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab 53: 556-559
39. Frohman LA, MacGillivray MH, Aceto T Jr (1967) Acute effects of human growth hormone on insulin secretion and glucose utilization in normal and growth hormone deficient subjects. J Clin Endocrinol Metab 27: 561-567
40. Fineberg SE, Merimee TJ (1974) Acute metabolic effects of human growth hormone. Diabetes 23: 499-504
41. Seng G, Galgoti C, Louisy P, Toussain P, Drouin P, Debry G (1989) Metabolic effects of a single administration of growth hormone on lipid and carbohydrate metabolism in normal-weight and obese subjects. Am J Clin Nutr 50: 1348-1354
42. Moller N, Jorgensen JOL, Schmitz O et al. (1990) Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 258:E86-E91
43. Fowelin J, Attvall S, Von Schenck H, Smith U, Lager I (1991) Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 34: 500-506
44. Martha PM, Jr., Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD (1992) Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: Relationship to age, pubertal status, and body mass. J Clin Endocrinol Metab 74: 336-344
45. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP (1981) Impaired growth hormone secretion in the adult population. J Clin Invest 67: 1361-1369
46. Andreotti AC, Lanzi R, Manzoni MF, Caumo A, Moreschi A, Pontiroli AE (1994) Acute pharmacologie blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. Metabolism 43: 1207-1213
47. Keller U, Schnell H, Girard J, Stauffacher W (1984) Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man. Diabetologia 26: 104-108
48. Jensen MD (1995) Gender differences in regional fatty acid metabolism before and after meal ingestion. J Clin Invest 96: 2297-2303
49. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA (1990) Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 259:E736-E750